Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Acer Therapeutics Inc.
DescriptionRepurposed celiprolol hydrochloride, a cardioselective adrenergic receptor beta 1 (ADRB1) antagonist
Molecular Target Adrenergic receptor beta 1 (ADRB1)
Mechanism of ActionAdrenergic receptor beta 1 (ADRB1) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard Indication Metabolic (unspecified)
Indication DetailsTreat vascular Ehlers-Danlos syndrome vEDS, EDS type IV)
Regulatory Designation U.S. - Orphan Drug (Treat vascular Ehlers-Danlos syndrome vEDS, EDS type IV))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today